UPDATE: FluimediX Closes $1.1M Financing Round | GenomeWeb

This article has been updated to report the total amount of funding in the round.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – FluimediX today said that it has closed a round of financing intended to support further development of its NanoCycler platform.

The Taastrup, Denmark-based firm raised DKK 6 million ($1.1 million) in the round that was led by Seed Capital Denmark. In addition, existing shareholders participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.